VERA (Vera Therapeutics) Common Stock: $0.07 Mil (As of Mar. 2026)


VERA Vera Therapeutics Inc VERA
34 GF Score
Price $41.08
! 3 Warning Signs
View Full Analysis

What is Vera Therapeutics Common Stock?

Vera Therapeutics VERA -0.30% 34 Common Stock is $0.07 Mil as of Mar. 2026. GuruFocus rates VERA with a GF Score™ of 34/100. The stock has 3 warning signs investors should review.

Vera Therapeutics's quarterly common stock increased from Sep. 2025 ($0.06 Mil) to Dec. 2025 ($0.07 Mil) and increased from Dec. 2025 ($0.07 Mil) to Mar. 2026 ($0.07 Mil).

Vera Therapeutics's annual common stock increased from Dec. 2023 ($0.04 Mil) to Dec. 2024 ($0.06 Mil) and increased from Dec. 2024 ($0.06 Mil) to Dec. 2025 ($0.07 Mil).

Vera Therapeutics Common Stock Historical Data

* Premium members only.

The historical data trend for Vera Therapeutics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vera Therapeutics Common Stock Chart

Vera Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial 0.02 0.03 0.04 0.06 0.07

Vera Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.06 0.06 0.07 0.07
VERA
34GF Score
Vera Therapeutics Inc VERA
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vera Therapeutics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.07 Mil mean?
Vera Therapeutics (VERA) has a Common Stock of $0.07 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Vera Therapeutics and its competitors.
Is Vera Therapeutics' Common Stock too high?
Vera Therapeutics' current Common Stock is $0.07 Mil. Overall, Vera Therapeutics has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Vera Therapeutics' Common Stock compare to RARE and IRON?
Vera Therapeutics' Common Stock of $0.07 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Vera Therapeutics and its competitors. Vera Therapeutics's current Common Stock is $0.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vera Therapeutics stock overvalued right now?
Vera Therapeutics (VERA) has a current Common Stock of $0.07 Mil. The current Common Stock is $0.07 Mil. Vera Therapeutics' overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Vera Therapeutics (VERA), the current Common Stock is $0.07 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vera Therapeutics Business Description

Address 2000 Sierra Point Parkway, Suite 1200, Brisbane, CA, USA, 94005
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
34GF Score

Get the complete analysis for VERA

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$41.08
Price